Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Levetiracetam - Generic Drug Details

« Back to Dashboard

What are the generic sources for levetiracetam and what is the scope of levetiracetam freedom to operate?

Levetiracetam
is the generic ingredient in six branded drugs marketed by Hi-tech Pharmacal, Teva Pharms, Secan Pharms, Dr Reddys Labs Ltd, Ucb Inc, Prinston Inc, Lotus Pharm Co Ltd, Tolmar, Mylan Labs Ltd, Actavis Labs Fl Inc, Intellipharmaceutics, Breckenridge Pharm, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Hetero Labs Ltd Iii, Zydus Pharms Usa Inc, Mylan, Vintage Pharms, Rouses Point Pharms, Sandoz, Lupin, Orchid Hlthcare, Sagent Pharms, Wockhardt, Invagen Pharms, Jubilant Life, Torrent Pharms Ltd, Allied Pharma Inc, Luitpold, Hq Speciality Pharma, Accord Hlthcare, Sun Pharm Inds Ltd, Eci Pharms Llc, Pharm Assoc, Actavis Elizabeth, Apotex Inc, Aprecia Pharms Co, Torrent Pharms, Sun Pharma Global, Anchen Pharms, Taro, Tris Pharma Inc, Silarx, Pharmadax Inc, Orit Labs Llc, Dexcel Pharma, Methapharm, Hospira Inc, Mylan Pharms Inc, Actavis Mid Atlantic, Hikma Farmaceutica, X Gen Pharms, Sun Pharm Inds, Virtus Pharms, Amneal Pharms, Lupin Ltd, Ajanta Pharma, Aurobindo Pharma, and Watson Labs Inc, and is included in eighty-seven NDAs. There are six patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Levetiracetam has forty-four patent family members in nineteen countries.

There are thirty-five drug master file entries for levetiracetam. Ninety-seven suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: levetiracetam

Tradenames:6
Patents:6
Applicants:59
NDAs:87
Drug Master File Entries: see list35
Suppliers / Packagers: see list97
Bulk Api Vendors: see list78
Clinical Trials: see list37
Patent Applications: see list3,044
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:levetiracetam at DailyMed

Pharmacology for Ingredient: levetiracetam

Tentative approvals for LEVETIRACETAM

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe250MGTABLET;ORAL
► Subscribe► Subscribe500MGTABLET;ORAL
► Subscribe► Subscribe1GMTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Virtus Pharms
LEVETIRACETAM
levetiracetam
TABLET, EXTENDED RELEASE;ORAL091291-001Sep 12, 2011ABRXNoNo► Subscribe► Subscribe
Prinston Inc
LEVETIRACETAM
levetiracetam
TABLET, EXTENDED RELEASE;ORAL203468-002May 21, 2015ABRXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
LEVETIRACETAM
levetiracetam
INJECTABLE;IV (INFUSION)203308-001Sep 16, 2016APRXNoNo► Subscribe► Subscribe
Prinston Inc
LEVETIRACETAM
levetiracetam
TABLET, EXTENDED RELEASE;ORAL203468-001May 21, 2015ABRXNoNo► Subscribe► Subscribe
Ajanta Pharma
LEVETIRACETAM
levetiracetam
TABLET;ORAL201293-003Jun 14, 2011ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot